Differential burden of comorbidities for Huntington’s Disease, Parkinson’s Disease and the general population for patients and care partners in the US
Objective: Describe the comorbidity burden for patients (pt) and care partners (cp) of Huntington’s Disease (HD), Parkinson’s Disease (PD) and the general population (GP) Background:…Longitudinal dynamics of mutant huntingtin and neurofilament light in Huntington’s disease: the prospective HD-CSF study
Objective: To present the mutant huntingtin (mHTT) and neurofilament light (NfL) findings from the two-year prospective longitudinal HD-CSF study, in which an 80-participant cohort of…Transcranial sonography in HIV infection: Does it reflect infectious and neurological symptoms?
Objective: To study whether transcranial sonography of brain parenchyma shows features with a potential association with clinical and neurological variables in human immunodeficiency virus (HIV)…Convolutional neural network for discriminating between Multiple System Atrophy and Healthy Control, comparing MRI modalities and highlighting the disease signature
Objective: To develop a neural network architecture based on multimodal MRI brain imaging to discriminate between multiple system atrophy (MSA) and healthy controls (HC), and…Feasibility of neurophysiological testing for differential diagnosis of functional tremor
Objective: This study aim of highlighting the difference in term of clinical characteristics, physical examination, risk factors, psychiatric comorbidity, and results of the neurophysiology test…Advance Care Planning in Complex Stage Parkinson’s Disease
Objective: Advance Care Planning (ACP) in patients with Complex stage Parkinson’s disease (PD) at the Royal Berkshire Foundation Trust (RBFT),Reading,United Kingdom. Background: In April 2019,…The sooner, the better: early diagnosis and treatment in functional neurological disorders
Objective: To assess the outcomes of an early intervention in patients with functional neurological disorders (FND) that presented acutely in our emergency department. Background: FND…Identification and characterization of anti-prionic compounds that disassemble Tau prions as a novel therapeutic approach for tauopathies
Objective: Stabilization of monomeric Tau protein by transient and high-affinity binding ligands is a novel and highly innovative anti-prionic treatment strategy for tauopathies. Background: Tauopathies…Robotic Assisted Arm Training in Parkinson’s disease rehabilitation: A pilot study
Objective: The aim and objective of this study was to evaluate whether robotic assisted arm training might improve upper limb function in patients with Parkinson’s…Understanding characteristics, healthcare resource use and costs of patients with Parkinson’s disease prior to and after diagnosis of cognitive impairment
Objective: The primary goal of this retrospective cohort study was to understand characteristics, healthcare resource use (HCRU) and costs of patients with PD before and…
- « Previous Page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- …
- 149
- Next Page »